Something Ventured Page #5
- NOT RATED
- Year:
- 2011
- 84 min
- 456 Views
bulbs for a whole summertime.
Light Bulb Company.
It's a little bit over the top,
but that's what it was.
I was a nerd.
A highly motivated, impatient,
driven workaholic nerd.
Um-Who accidentally
became an athlete,
and got some sort
of social polish...
at a school for nerds-MIT.
I scrambled to get into a degree where
I thought I could earn a living,
which was electronic engineering.
I did that for a while, and I thought,
"God, this is pretty boring."
And I thought, "Well, you know,
I've heard about business school.
Maybe I should
take a crack at that."
And this is where I got inspired
by Georges Doriot.
Professor Georges Doriot...
was a father figure
to a generation of young men...
This French expatriate
had the distinction of starting..
The first corporation dedicated
exclusively to venture investing,
American Research and Development,
founded in 1946.
Ironically, Doriot's lasting impact...
would not be through A.R.D.,
which in its entire 25-year history
made only one notable investment.
Instead, Doriot's
most important influence...
came through the spell he cast
over his Harvard classroom.
Doriot was very controversial...
even at the time at Harvard.
He taught a course
called Manufacturing,
which really had nothing to do
with manufacturing.
And it was an extremely
popular course,
and it was all about starting companies,
and technology.
He talked about entrepreneurs.
He had some of them as guests-
what it was like
to start a company.
His lectures were how to dress,
how many drinks you should have
at a cocktail party.
It was sort of a Georges Doriot
philosophy of life.
Every year, he'd take
one whole session...
on how to read
the New York Times.
He'd hold up the paper and say-
"You should be able to read
this paper in four minutes.
What is the first section I read?"
He said, "Now the first thing you want
to do is go to the obituary page.
There you will learn
the lives that are important,
and the kind of life
that you can build for yourself."
with entrepreneurs.
And when times got tough,
as they always will-
and he made that point-
that he would invite
the entrepreneur over to his home.
They'd have dinner, and then he'd
just sit him down in his library...
and play phonograph records
of French marching music.
You know, just to deal with
the psychological wounds, you know.
When he was talking about
venture capital, starting companies,
he was as good as there was, because
he was the only guy who understood it.
I bought it all-
hook, line, sinker.
Yeah, the best things
inlifeare free
But you can give them
to the birds and bees
I want money
That's what I want
So give me muh, uh-huh,
mo-mo-money
At the time we started Genentech,
there was no such thing
as genetic engineering.
And to take the idea
of commercializing gene splicing,
the risks were just enormous.
And I said, "Well, you know,
what if God or Darwin won't
let us make a new life form?"
It was a bet on technology,
and you looked at the value of
the pharmaceutical industry,
and if you had a better
way to develop drugs,
the power was enormous.
Nobody had a clue
whether they could pull that off,
but you did know...
that if they could, it was big.
It came out of the blue for me.
I had not been thinking
about starting a company.
I thought I was going to, uh, die at the
lab bench with a pipette in my mouth.
But, uh, Bob called,
and he wanted to know if the technology
was ready to be commercialized.
Bob Swanson, I think, was the most
prescient individual I've ever met.
Once he understood...
what the potential technology was
in genetic engineering,
he got the whole picture,
Eugene and I were looking around
for someone to add to the partnership,
and Bob joined us.
But there just wasn't enough
going on in those days, amazingly,
to really have him
full-time working on our ventures.
We didn't have that many.
But we were interested in doing
something in genetic engineering.
We sort of said,
"Go there, find something.
And if you can, we'll finance it.
If you can't, well-"
You know.
So he was motivated
to find something.
And he calls Professor Boyer
at the University of California.
Boyer said,
"I'll give you five minutes."
It turned into,
you know, many hours.
In those days, funding
for research was, uh, difficult.
And so, you know, I had some,
you know, ulterior reasons...
for paying attention
when he said he had money.
Over the next couple of weeks,
Swanson persuaded Boyer...
to take the idea of gene splicing into
some sort of a commercial operation.
So we go into one of
the, uh, Embarcadero Towers,
and we go up to the top floor.
And you can
look out over the world.
It was something like out of a movie,
and holy smoke.
So we go in, and these stern-looking guys
are sitting there in a suit, you know.
Perkins says,
"Okay, Well, what are you going to do?"
What do you do?
What equipment do you need?
How do you know that you've done it?
How do you test?
It's scary.
What are the risks? Contamination?
Everything I could think-
Here was this rich guy, you know, talking
to us about science, and funding science.
I paid attention, you know.
And I didn't know anything
about raising money.
Of course, I knew nothing whatsoever
about the technology. I mean, nobody did.
I had to rely on him.
Because there was so much
to be done.
He was a very hands-on guy.
They wanted to raise, um' about three
million dollars to build the factory,
hire the people,
and then see if it would work.
But underlying it all...
was the-the tremendous risk factor of,
you know, would it be possible?
It was pure research, you know,
and everybody knows that venture capitalists
shouldn't openly fund pure research.
So my idea in everything has always
been to try to put the risk up front...
and get rid of the risk
as fast as you possibly can.
Bob and I were very naive...
about how we were going
to do what we did.
I persuaded them to do it
a different way.
To subcontract the experiment
to two different institutions.
By subcontracting,
Tom Perkins eliminated the need...
to buy equipment, build a lab
and hire staff.
The estimated three million dollar
start-up costs...
were reduced to just 250,000.
Kleiner Perkins put up the money,
and Genentech was in business.
It was Bob Swanson and a checkbook
sitting in our office here.
That was Genentech.
Boyer and Swanson set out
to create human insulin.
But, to test their concept,
they began with a less complex hormone.
City of Hope Medical Center
in Los Angeles...
would try to engineer a gene
for that hormone.
splice that gene into bacteria...
to produce the hormone
in significant amounts.
After a very long time, City of Hope
Translation
Translate and read this script in other languages:
Select another language:
- - Select -
- 简体中文 (Chinese - Simplified)
- 繁體中文 (Chinese - Traditional)
- Español (Spanish)
- Esperanto (Esperanto)
- 日本語 (Japanese)
- Português (Portuguese)
- Deutsch (German)
- العربية (Arabic)
- Français (French)
- Русский (Russian)
- ಕನ್ನಡ (Kannada)
- 한국어 (Korean)
- עברית (Hebrew)
- Gaeilge (Irish)
- Українська (Ukrainian)
- اردو (Urdu)
- Magyar (Hungarian)
- मानक हिन्दी (Hindi)
- Indonesia (Indonesian)
- Italiano (Italian)
- தமிழ் (Tamil)
- Türkçe (Turkish)
- తెలుగు (Telugu)
- ภาษาไทย (Thai)
- Tiếng Việt (Vietnamese)
- Čeština (Czech)
- Polski (Polish)
- Bahasa Indonesia (Indonesian)
- Românește (Romanian)
- Nederlands (Dutch)
- Ελληνικά (Greek)
- Latinum (Latin)
- Svenska (Swedish)
- Dansk (Danish)
- Suomi (Finnish)
- فارسی (Persian)
- ייִדיש (Yiddish)
- հայերեն (Armenian)
- Norsk (Norwegian)
- English (English)
Citation
Use the citation below to add this screenplay to your bibliography:
Style:MLAChicagoAPA
"Something Ventured" Scripts.com. STANDS4 LLC, 2024. Web. 22 Dec. 2024. <https://www.scripts.com/script/something_ventured_18472>.
Discuss this script with the community:
Report Comment
We're doing our best to make sure our content is useful, accurate and safe.
If by any chance you spot an inappropriate comment while navigating through our website please use this form to let us know, and we'll take care of it shortly.
Attachment
You need to be logged in to favorite.
Log In